Home › Funds › Affinity Asset Advisors, LLC › CATX
Affinity Asset Advisors, LLC position in CATX
PERSPECTIVE THERAPEUTICS INC · Health Care
Affinity Asset Advisors, LLC reported holding 3,988,744 shares of CATX (PERSPECTIVE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$11.0M, representing 0.51% of its reported portfolio and ranking #45 among its reported holdings. Affinity Asset Advisors, LLC has disclosed CATX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Affinity Asset Advisors, LLC's CATX position evolved
Affinity Asset Advisors, LLC first disclosed a stake in CATX in Q1 2024 at 5,100,000 shares (US$6.1M). The position peaked in Q2 2026 at 4,214,582 shares, worth US$14.4M. Across 11 filings, Affinity Asset Advisors, LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,988,744 shares valued at US$11.0M — a reduction of -225,838 shares quarter over quarter.. Notable position changes include a 89% trim in Q2 2024 (shares rose 34% over the following quarter), a 160% increase in Q4 2024 (shares fell 33% over the following quarter), a 955% increase in Q1 2026 (shares fell 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 5.10M | $6.07M | New |
| Q2 2024 | 550.00K | $5.48M | Reduce |
| Q3 2024 | 500.00K | $6.67M | Reduce |
| Q4 2024 | 1.30M | $4.15M | Add |
| Q1 2025 | 2.22M | $4.74M | Add |
| Q2 2025 | 1.05M | $3.61M | Reduce |
| Q3 2025 | 300.00K | $1.03M | Reduce |
| Q4 2025 | 300.00K | $825.00K | Hold |
| Q1 2026 | 3.16M | $13.20M | Add |
| Q2 2026 | 4.21M | $14.37M | Add |
| Q3 2026 | 3.99M | $10.97M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CATX and 13F data
CATX (PERSPECTIVE THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in CATX — the largest reported positions include TCG Crossover Management, LLC (US$27.0M), Commodore Capital LP (US$21.6M), Avidity Partners Management LP (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CATX
- TCG Crossover Management, LLC 7.92M sh · $26.99M · Q2 2026
- Commodore Capital LP 6.34M sh · $21.61M · Q2 2026
- Avidity Partners Management LP 6.30M sh · $21.48M · Q2 2026
- Spruce Street Capital LP 3.69M sh · $10.16M · Q3 2026
- Nicholson Wealth Management Group, LLC 1.62M sh · $4.45M · Q3 2026
- Yu Fan 1.06M sh · $3.60M · Q2 2026
- Ally Bridge Group (NY) LLC 743.96K sh · $2.54M · Q2 2026
More on Affinity Asset Advisors, LLC
FAQ
How long has Affinity Asset Advisors, LLC held CATX?
Affinity Asset Advisors, LLC has disclosed CATX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Affinity Asset Advisors, LLC's current position in CATX?
As of Q3 2026, Affinity Asset Advisors, LLC holds 3.99M shares of CATX (PERSPECTIVE THERAPEUTICS INC), valued at $10.97M, representing 0.51% of its reported portfolio and ranking #45.
Has Affinity Asset Advisors, LLC been buying or selling CATX?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC reduced its position in CATX. The position peaked in Q2 2026 at 4.21M shares.
Which other funds hold CATX?
Other major institutional holders of CATX include TCG Crossover Management, LLC, Commodore Capital LP, Avidity Partners Management LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.